P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)
Year: 2025
Type: conference-abstract
Authors: Jonathan Fallowfield, Mark Thursz, Neil Guha, Manuel Rodriguez-Peralvarez, Esther Kitto, Faisal Sheikh, Cliff Brass
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414963764